EBS
Emergent Biosolutions Inc
Halal Rating :
Last Price
$10.00
Last updated:
Market Cap
-
7D Change
6.27%
1 Year Change
407.61%
Company Overview
Industries
Exchange
Next Earnings Date
Emergent BioSolutions Inc. is a biopharmaceutical company that develops, manufactures, and delivers vaccines and therapeutics for infectious diseases, opioid overdoses, and chemical, biological, radiological, and nuclear threats. The company provides medical countermeasures to civilian and military populations through both commercial sales and government contracts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $562.9m | $351.9m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $438.1m | $481.8m | - | $23.6m | 0.00% | 4.90% |
| March 31, 2024 | $200000.0 | $690.1m | - | $24.3m | 0.00% | 3.52% |
Company Impact
Help us evaluate Emergent Biosolutions Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.